Dec 07, 2023 / 01:30PM GMT
Eva Schaefer-Jansen - Sanofi - Head of IR
So good morning. Thank you for joining us here in New York. For the next couple of hours -- that was too fast. For the next couple of really looking forward to sharing with you the progress that we've been making with our pipeline and also with our R&D transformation overall.
You may remember that in summer 2022, we highlighted the up to 30 early- to mid-stage readouts we were looking for in the next 18 months. And now we're here today in the heart of the world's financial center, home to our second listing, we're going through a number of those results, and more importantly, what they mean for us, what opportunities they can create for us.
Also welcome to those that are joining us on the webcast today. You may be looking at a large slide and at a small picture. You may or may not know that you can actually adjust the view in the video (technical difficulty) and for you to potentially play with that now, we're going to start a small video.
So could we have the video, please?
(presentation)
Sanofi SA R&D Day Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers